During the past decade, Jüdisches Krankenhaus Berlin; Abteilung fur Neurologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jüdisches Krankenhaus Berlin; Abteilung fur Neurologie" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Jüdisches Krankenhaus Berlin; Abteilung fur Neurologie" are "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Jüdisches Krankenhaus Berlin; Abteilung fur Neurologie" in a lesser frequency.

Most popular intervention types in "Jüdisches Krankenhaus Berlin; Abteilung fur Neurologie" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (4 trials), "Placebo" (3 trials), "Avonex" (1 trials), "Fenebrutinib" (1 trials) and "Teriflunomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jüdisches Krankenhaus Berlin; Abteilung fur Neurologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Jüdisches Krankenhaus Berlin; Abteilung fur Neurologie". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Jüdisches Krankenhaus Berlin; Abteilung fur Neurologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jüdisches Krankenhaus Berlin; Abteilung fur Neurologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".